510(k) Report

510(k) · Cleared

Cleared

Localite TMS Navigator TS

K223577510(k) TraditionalCleared Apr 17, 2023138-day reviewClass II21 CFR 882.4560

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Localite GmbH · HAW Neurological Stereotaxic Instrument

Cleared on Apr 17, 2023 as substantially equivalent to K191422 (Soterix Medical, Inc., 2020) and 1 other predicate after a 138-day review. Its family tree reaches back 7 generations to 2008. 2 later devices descend from it.

Decided
Apr 17, 2023
Review
138 days
Class
Class II
Product code
HAW
Recalls
None
Predicates
2

Its longest line of descent runs back 7 generations to DEN070003 (2008). 2 later devices descend from it, 1 citing it directly.

  1. Root · 7 generations backDEN070003 Neurostar TMS SystemNeuronetics · 2008
  2. 6 generations backK083538 Neurostar TMS Therapy System, Model 1.1Neuronetics · 2008 · Recalled
  3. 5 generations backK130233 Neurostar TMS Therapy SystemNeuronetics · 2013
  4. 4 generations backK133408 Neurostar TMS Therapy SystemNeuronetics · 2014
  5. 3 generations backK143531 Rapid Therapy SystemMagstim Company Limited · 2015 · Recalled
  6. 2 generations backK171902 Nexstim Navigated Brain Therapy (NBT) System 2Nexstim Plc · 2017
  7. 1 generation backK191422 Neural NavigatorSoterix Medical, Inc. · 2020
  8. This deviceK223577 Localite TMS Navigator TSLocalite GmbH · 2023
  9. Descendant · cites it directly · 1 of its ownK251927 Zeta Navigation System (ZNS131-US)Zeta Surgical, Inc. · 2025
  10. Descendant · 2 generations on · 0 of its ownK261471 Zeta TMS Navigation SystemZeta Surgical, Inc. · 2026

Most influential descendants

Showing 2 of 2 · See all
  • K251927Zeta Navigation System (ZNS131-US)Zeta Surgical, Inc. · 2025 · cites it directly1descendant
  • K261471Zeta TMS Navigation SystemZeta Surgical, Inc. · 2026 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7DEN070003Neurostar TMS SystemNeuronetics2008—
−6K083538Neurostar TMS Therapy System, Model 1.1Neuronetics20081
−5K130233Neurostar TMS Therapy SystemNeuronetics2013—
−4K133408Neurostar TMS Therapy SystemNeuronetics2014—
−3K143531Rapid Therapy SystemMagstim Company Limited20153
−2K171902Nexstim Navigated Brain Therapy (NBT) System 2Nexstim Plc2017—
−1K191422Neural NavigatorSoterix Medical, Inc.2020—
0 (this device)K223577Localite TMS Navigator TSLocalite GmbH2023—
+1K251927Zeta Navigation System (ZNS131-US)Zeta Surgical, Inc.2025—
+2K261471Zeta TMS Navigation SystemZeta Surgical, Inc.2026—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
202610
FIG. 1 — Lineage of K223577, 2008–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HAW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HAW device

  1. #1 K253856 Geniant Cranial (Navigated Neurosurgical…score 15.0 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K191422Neural Navigator
Summary page 4
…ber 882.4560 Product Code HAW I Legally Marketed Predicate Devices 21 CFR 807.92(a)(3) Predicate # Predicate Trade Name (Primary Predicate is listed first) Product Code K191422 The Neural Navigator HAW K171902 Nexstim Navigated Brain Therapy (NBT) System 2 HAW Device Description Summary 21 CFR 807.92(a)(4…
Soterix Medical, Inc.2020—
*K171902Nexstim Navigated Brain Therapy (NBT) System 2
Summary page 4
…Legally Marketed Predicate Devices 21 CFR 807.92(a)(3) Predicate # Predicate Trade Name (Primary Predicate is listed first) Product Code K191422 The Neural Navigator HAW K171902 Nexstim Navigated Brain Therapy (NBT) System 2 HAW Device Description Summary 21 CFR 807.92(a)(4) The TMS Navigator TS is a navi…
Nexstim Plc2017—

Also cleared against K191422: 3 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K251927Zeta Navigation System (ZNS131-US)Zeta Surgical, Inc.20251

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 15 years and passes through 5 companies; a new generation was cleared every 2.4 years on median.
  • 2 of the 7 ancestors have a recall of any class.
  • Of its descendants, K251927 (Zeta Surgical, Inc., 2025) has gone furthest, with 1 descendant of its own.
  • 3 other devices also cite its predicate K191422.

How does its category compare?

All HAW devices

HAW Neurological Stereotaxic Instrument: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.

FDA decisions per year · HAW

9in 2025

2007: 152008: 122009: 82010: 62011: 42012: 82013: 32014: 52015: 102016: 92017: 72018: 62019: 102020: 52021: 92022: 72023: 142024: 72025: 92026 (partial year): 5
2007high 15 (2007) · low 3 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HAW

163in 2025

2007: 107 days median2008: 112 days median2009: 221 days median2010: 138 days median2011: 66 days median2012: 178 days median2013: 172 days median2014: 238 days median2015: 232 days median2016: 175 days median2017: 226 days median2018: 112 days median2019: 147 days median2020: 88 days median2021: 168 days median2022: 128 days median2023: 142 days median2024: 107 days median2025: 163 days median2026 (partial year): 162 days median
2007high 238 (2014) · low 66 (2011)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HAW

2in 2025

2007: 22008: 102009: 62010: 282011: 52012: 42013: 6, 1 Class I2014: 52015: 32016: 52017: 22018: 2, 2 Class I2019: 4, 1 Class I2020: 12021: 4, 2 Class I2022: 12023: 4, 1 Class I2024: 2, 2 Class I2025: 22026 (partial year): 6
2007high 28 (2010) · low 1 (2020)2026

Class I (9 since 2007) Class II/III not classified

Adverse event reports per year · HAW

3,425in 2025

2007: 492008: 532009: 962010: 2992011: 1,7252012: 9862013: 1,2902014: 1,6062015: 1,7672016: 1,8282017: 3,5052018: 4,4392019: 6,0622020: 3,4802021: 2,8272022: 1,9292023: 2,5102024: 3,7552025: 3,425
2007high 6,062 (2019) · low 49 (2007)2025

MAUDE reports naming product code HAW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200715107249
2008121121053
20098221696
2010613828299
201146651,725
201281784986
201331726 (1)1,290
2014523851,606
20151023231,767
2016917551,828
2017722623,505
201861122 (2)4,439
2019101474 (1)6,062
202058813,480
202191684 (2)2,827
2022712811,929
2023141424 (1)2,510
202471072 (2)3,755
2025916323,425
202651626—

What is it indicated for?

The TMS Navigator TS helps users to plan, implement and document treatment involving TMS of the brain. The system provides planning and navigation functions using anatomical MR data. Regions of the brain to be stimulated can be determined on the basis of anatomy, functional areas or by entering previously calculated coordinates from brain atlases. The product is intended for use with the MagVenture therapy systems supplied by Tonica Elektronik A/S…

Read the full statement (112 words)

The TMS Navigator TS helps users to plan, implement and document treatment involving TMS of the brain.

The system provides planning and navigation functions using anatomical MR data.

Regions of the brain to be stimulated can be determined on the basis of anatomy, functional areas or by entering

previously calculated coordinates from brain atlases.

The product is intended for use with the MagVenture therapy systems supplied by Tonica Elektronik A/S (Farum,

Denmark), more precisely the R20 and R30 stimulators, the R30 TMS stimulator with MagOption, the X100 stimulator

and the X100 stimulator with MagOption only with following magnetic coils: C-100, C-B60, Cool-B65, Cool-B70, Cool

D-B80, MC-125, MC-B70, MCF-75, MCF-125, MCF-B65 and MMC-140-II.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K223577: Localite TMS Navigator TS.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K223577

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026